Description

According to WHO’s statistics, at least 10% of world population suffer from various kinds of mental illnesses. According to the statistics published by the National Center for Mental Health, China-CDC, the number of cases of mental illnesses is more than 100 million, among which 16 million suffer from holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ranking first in the total burden of disease in China.

View Full Report at: http://www.marketresearchreports.biz/analysis/294875

As an atypical antipsychotic, olanzapine is mainly used for the treatment of the positive symtoms of schizophrenia and it also has some curative effects on schizophrenia’s negative symtoms. Developed on the base of clozapine, the former generation of antipsychotic medication, olanzapine was approved by Food and Drug Administration (FDA) to go on sale in 1996 and its patent held by Eli Lilly expired in 2011. The preparations of olanzapine available in mainland China include domestic Oulaining, Ximin and imported Zyperxa.

As a drug for schizophrenia, olanzapine entered the European and American market in 1996 and then the Chinese market in 1999. In 2003, it was even rated as the first-line drug in the Guidelines for Prevention and Control of Schizophrenia. Olanzapine develops fast after entering China, annual sales value rising from less than CNY 40 million in 2005 to CNY 420 million in 2014 and CAGR during this period reaching 30%. Hanson Pharmaceutical, Changzhou Watson Pharmaceuticals Co., Ltd and Eli Lilly and Company occupy the major market share, among which Hanson Pharmaceutical has the largest market share of about 44% for sales value in 2014.

With the change of life styles and the increased stress in work and life brought about by China’s economic development, the incidence of mental illness and psychological problems is growing. Therefore, the market size of olanzapine in China is expected to keep expanding in the next few years.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/294875



Readers can get at least the following information from this report:

market size of olanzapine in China
competitive landscape of olanzapine in Chinese market
price of olanzapine made by different enterprises in China
market outlook of olanzapine in China

The author suggests the following groups of people purchase this report:

manufacturers of antipsychotics
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service


Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz


Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: [email protected]